These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 12115627)

  • 1. T cell receptor transgenic mice recognizing the immunodominant epitope of the Torpedo californica acetylcholine receptor.
    Lobito AA; Yang B; Lopes MF; Miagkov A; Adams RN; Palardy GR; Johnson MM; McFarland HI; Recher M; Drachman DB; Lenardo MJ
    Eur J Immunol; 2002 Jul; 32(7):2055-67. PubMed ID: 12115627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmune responses against acetylcholine receptor: T and B cell collaboration and manipulation by synthetic peptides.
    Atassi MZ; Oshima M
    Crit Rev Immunol; 1997; 17(5-6):481-95. PubMed ID: 9419435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4+ T and B cells cooperate in the immunoregulation of Experimental Autoimmune Myasthenia Gravis.
    Milani M; Ostlie N; Wu H; Wang W; Conti-Fine BM
    J Neuroimmunol; 2006 Oct; 179(1-2):152-62. PubMed ID: 16945426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B-cell activation in vitro by helper T cells specific to region alpha 146-162 of Torpedo californica nicotinic acetylcholine receptor.
    Rosenberg JS; Oshima M; Atassi MZ
    J Immunol; 1996 Oct; 157(7):3192-9. PubMed ID: 8816433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the initial trigger of myasthenia gravis and suppression of the disease by antibodies against the MHC peptide region involved in the presentation of a pathogenic T-cell epitope.
    Atassi MZ; Oshima M; Deitiker P
    Crit Rev Immunol; 2001; 21(1-3):1-27. PubMed ID: 11642597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental myasthenia gravis in congenic mice. Sequence mapping and H-2 restriction of T helper epitopes on the alpha subunits of Torpedo californica and murine acetylcholine receptors.
    Bellone M; Ostlie N; Lei S; Conti-Tronconi BM
    Eur J Immunol; 1991 Oct; 21(10):2303-10. PubMed ID: 1680694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of amino acid substitutions within the region 62-76 of I-A beta b on binding with and antigen presentation of Torpedo acetylcholine receptor alpha-chain peptide 146-162.
    Oshima M; Atassi MZ
    J Immunol; 1995 May; 154(10):5245-54. PubMed ID: 7537303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cryptic epitopes on the nicotinic acetylcholine receptor are recognized by autoreactive CD4+ cells.
    Bellone M; Ostlie N; Karachunski P; Manfredi AA; Conti-Tronconi BM
    J Immunol; 1993 Jul; 151(2):1025-38. PubMed ID: 7687612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The I-Abm12 mutation, which confers resistance to experimental myasthenia gravis, drastically affects the epitope repertoire of murine CD4+ cells sensitized to nicotinic acetylcholine receptor.
    Bellone M; Ostlie N; Lei SJ; Wu XD; Conti-Tronconi BM
    J Immunol; 1991 Sep; 147(5):1484-91. PubMed ID: 1715360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Th2 cytokine IL-4 is not required for the progression of antibody-dependent autoimmune myasthenia gravis.
    Balasa B; Deng C; Lee J; Christadoss P; Sarvetnick N
    J Immunol; 1998 Sep; 161(6):2856-62. PubMed ID: 9743346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental autoimmune myasthenia gravis in B10.BV8S2 transgenic mice: preferential usage of TCRAV1 gene by lymphocytes responding to acetylcholine receptor.
    Kaul R; Wu B; Goluszko E; Deng C; Dedhia V; Nabozny GH; David CS; Rimm IJ; Shenoy M; Haqqi TM; Christadoss P
    J Immunol; 1997 Jun; 158(12):6006-12. PubMed ID: 9190955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TCR gene usage in experimental autoimmune myasthenia gravis pathogenesis. Usage of multiple TCRBV genes in the H-2b strains.
    Wu B; Shenoy M; Goluszko E; Kaul R; Christadoss P
    J Immunol; 1995 Apr; 154(7):3603-10. PubMed ID: 7897239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly conserved TCR beta chain CDR3 sequences among immunodominant acetylcholine receptor-reactive T cells in murine myasthenia gravis.
    Pierce JL; Zborowski KA; Kraig E; Infante AJ
    Int Immunol; 1994 May; 6(5):775-83. PubMed ID: 8080845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preferential pairing of T and B cells for production of antibodies without covalent association of T and B epitopes.
    Bellone M; Karachunski PI; Ostlie N; Lei S; Conti-Tronconi BM
    Eur J Immunol; 1994 Apr; 24(4):799-804. PubMed ID: 7512029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of experimental myasthenia gravis by nasal administration of synthetic acetylcholine receptor T epitope sequences.
    Karachunski PI; Ostlie NS; Okita DK; Conti-Fine BM
    J Clin Invest; 1997 Dec; 100(12):3027-35. PubMed ID: 9399949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preferential use of a T cell receptor V beta gene by acetylcholine receptor reactive T cells from myasthenia gravis-susceptible mice.
    Infante AJ; Levcovitz H; Gordon V; Wall KA; Thompson PA; Krolick KA
    J Immunol; 1992 Jun; 148(11):3385-90. PubMed ID: 1375242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A disease-related epitope of Torpedo acetylcholine receptor. Residues involved in I-Ab binding, self-nonself discrimination, and TCR antagonism.
    Wall KA; Hu JY; Currier P; Southwood S; Sette A; Infante AJ
    J Immunol; 1994 May; 152(9):4526-36. PubMed ID: 8157967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-17-producing CD4(+) T cells contribute to the loss of B-cell tolerance in experimental autoimmune myasthenia gravis.
    Schaffert H; Pelz A; Saxena A; Losen M; Meisel A; Thiel A; Kohler S
    Eur J Immunol; 2015 May; 45(5):1339-47. PubMed ID: 25676041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of T helper cell precursor frequency on vesicular stomatitis virus neutralizing antibody responses in a T cell receptor beta chain transgenic mouse.
    Freer G; Burkhart C; Rülicke T; Ghelardi E; Rohrer UH; Pircher H; Zinkernagel RM; Hengartner H
    Eur J Immunol; 1995 May; 25(5):1410-6. PubMed ID: 7539759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ICOS is essential for the development of experimental autoimmune myasthenia gravis.
    Scott BG; Yang H; Tüzün E; Dong C; Flavell RA; Christadoss P
    J Neuroimmunol; 2004 Aug; 153(1-2):16-25. PubMed ID: 15265659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.